Galderma Patent for Brimonidine Foam

[Guide]

Galderma has applied for a brimonidine foam patent which according to the patent is claimed to have the "advantage of remaining on the surface of the skin and of delivering a smaller amount so as to prevent undesirable effects (rebound effect) and too obtain a foam that is suitable for treating rosacea."

US20190099369A1.pdf